+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)

Remote Patient Monitoring Devices In Europe

  • PDF Icon

    Report

  • 46 Pages
  • April 2025
  • Region: Europe
  • GlobalData
  • ID: 6145261
Remote Patient Monitoring Devices in Europe industry profile provides top-line qualitative and quantitative summary information including: market share, market size (value and volume 2019-24, and forecast to 2029). The profile also contains descriptions of the leading players including key financial metrics and analysis of competitive pressures within the market.

Key Highlights

  • Remote patient monitoring (RPM) involves the utilization of digital technologies and services to oversee, analyze, and capture patients' health data, which is subsequently transmitted to healthcare professionals for thorough assessment. Market scope excludes glucose monitoring devices and neurological monitors.
  • The European remote patient monitoring devices market recorded revenues of $1.11 billion in 2024, representing a compound annual growth rate (CAGR) of 3.9% between 2019 and 2024.
  • The implantable remote patient monitoring devices segment accounted for the market's largest proportion in 2024, with total revenues of $738.2 million, equivalent to 65.9% of the market's overall value.
  • In 2024, Germany accounted for a share of 12.1% of the European remote patient monitoring devices market, making it the largest market in the region.

Scope

  • Save time carrying out entry-level research by identifying the size, growth, major segments, and leading players in the remote patient monitoring devices market in Europe
  • Use the Five Forces analysis to determine the competitive intensity and therefore attractiveness of the remote patient monitoring devices market in Europe
  • Leading company profiles reveal details of key remote patient monitoring devices market players’ global operations and financial performance
  • Add weight to presentations and pitches by understanding the future growth prospects of the Europe remote patient monitoring devices market with five year forecasts by both value and volume

Reasons to Buy

  • What was the size of the Europe remote patient monitoring devices market by value in 2024?
  • What will be the size of the Europe remote patient monitoring devices market in 2029?
  • What factors are affecting the strength of competition in the Europe remote patient monitoring devices market?
  • How has the market performed over the last five years?
  • Who are the top competitors in Europe's remote patient monitoring devices market?

Table of Contents

1 Executive Summary
1.1. Market value
1.2. Market value forecast
1.3. Category segmentation
1.4. Geography segmentation
1.5. Market rivalry
1.6. Competitive landscape
2 Market Overview
2.1. Market definition
2.2. Market analysis
3 Market Data
3.1. Market value
4 Market Segmentation
4.1. Category segmentation
4.2. Geography segmentation
5 Market Outlook
5.1. Market value forecast
6 Five Forces Analysis
6.1. Summary
6.2. Buyer power
6.3. Supplier power
6.4. New entrants
6.5. Threat of substitutes
6.6. Degree of rivalry
7 Competitive Landscape
7.1. Who are the key market players?
7.2. What are the strengths and strategies of the players?
7.3. What are the recent market developments?
8 Company Profiles
8.1. Biotronik SE & Co KG
8.2. Koninklijke Philips NV
8.3. Robert Bosch Healthcare Systems Inc
8.4. Abbott Laboratories
9 Macroeconomic Indicators
9.1. Country data
10 Appendix
10.1. Methodology
10.2. Industry associations
10.3. Related the analyst research
10.4. About the Analyst
List of Tables
Table 1: Europe remote patient monitoring devices market value: $ million, 2019-24
Table 2: Europe remote patient monitoring devices market category segmentation: % share, by value, 2019-24
Table 3: Europe remote patient monitoring devices market category segmentation: $ million, 2019-24
Table 4: Europe remote patient monitoring devices market geography segmentation: $ million, 2024
Table 5: Europe remote patient monitoring devices market value forecast: $ million, 2024-29
Table 6: Biotronik SE & Co KG: Key Facts
Table 7: Biotronik SE & Co KG: key employees
Table 8: Koninklijke Philips NV: Key Facts
Table 9: Koninklijke Philips NV: annual financial ratios
Table 10: Koninklijke Philips NV: key employees
Table 11: Robert Bosch Healthcare Systems Inc: Key Facts
Table 12: Robert Bosch Healthcare Systems Inc: key employees
Table 13: Abbott Laboratories: Key Facts
Table 14: Abbott Laboratories: annual financial ratios
Table 15: Abbott Laboratories: key employees
Table 16: Abbott Laboratories: key employees Continued
Table 17: Europe Size of Population (Million), 2020-24
Table 18: Europe Real GDP (Constant 2010 Prices, $ Billion), 2020-24
Table 19: Europe GDP (Current Prices, $ Billion), 2020-24
Table 20: Europe Inflation, 2020-24
Table 21: Europe Consumer Price Index (Absolute), 2020-24
Table 22: Europe Exchange Rate, 2019-24
List of Figures
Figure 1: Europe remote patient monitoring devices market value: $ million, 2019-24
Figure 2: Europe remote patient monitoring devices market category segmentation: $ million, 2019-24
Figure 3: Europe remote patient monitoring devices market geography segmentation: % share, by value, 2024
Figure 4: Europe remote patient monitoring devices market value forecast: $ million, 2024-29
Figure 5: Forces driving competition in the remote patient monitoring devices market in Europe, 2024
Figure 6: Drivers of buyer power in the remote patient monitoring devices market in Europe, 2024
Figure 7: Drivers of supplier power in the remote patient monitoring devices market in Europe, 2024
Figure 8: Factors influencing the likelihood of new entrants in the remote patient monitoring devices market in Europe, 2024
Figure 9: Factors influencing the threat of substitutes in the remote patient monitoring devices market in Europe, 2024
Figure 10: Drivers of degree of rivalry in the remote patient monitoring devices market in Europe, 2024

Companies Mentioned (Partial List)

A selection of companies mentioned in this report includes, but is not limited to:

  • Biotronik SE & Co KG
  • Koninklijke Philips NV
  • Robert Bosch Healthcare Systems Inc
  • Abbott Laboratories